These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29593436)

  • 1. Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis.
    van Eijk RP; Eijkemans MJ; Rizopoulos D; van den Berg LH; Nikolakopoulos S
    Clin Epidemiol; 2018; 10():333-341. PubMed ID: 29593436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open-Access ALS Clinical Trials cohort.
    Thakore NJ; Lapin BR; Pioro EP;
    Muscle Nerve; 2018 Jun; 57(6):937-945. PubMed ID: 29244213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Item response theory analysis of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised in the Pooled Resource Open-Access ALS Clinical Trials Database.
    Bacci ED; Staniewska D; Coyne KS; Boyer S; White LA; Zach N; Cedarbaum JM;
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(3-4):157-67. PubMed ID: 26473473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis.
    Andrews JA; Meng L; Kulke SF; Rudnicki SA; Wolff AA; Bozik ME; Malik FI; Shefner JM
    JAMA Neurol; 2018 Jan; 75(1):58-64. PubMed ID: 29181534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering.
    Tang M; Gao C; Goutman SA; Kalinin A; Mukherjee B; Guan Y; Dinov ID
    Neuroinformatics; 2019 Jul; 17(3):407-421. PubMed ID: 30460455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PRO-ACT database: design, initial analyses, and predictive features.
    Atassi N; Berry J; Shui A; Zach N; Sherman A; Sinani E; Walker J; Katsovskiy I; Schoenfeld D; Cudkowicz M; Leitner M
    Neurology; 2014 Nov; 83(19):1719-25. PubMed ID: 25298304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials.
    Daghlas I; Lever TE; Leary E
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):206-211. PubMed ID: 29260911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
    Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
    J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach.
    Thakore NJ; Lapin BR; Kinzy TG; Pioro EP
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):483-494. PubMed ID: 30001159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.
    van Eijk RPA; Eijkemans MJC; Ferguson TA; Nikolakopoulos S; Veldink JH; van den Berg LH
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):156-161. PubMed ID: 29084868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials.
    Berry JD; Miller R; Moore DH; Cudkowicz ME; van den Berg LH; Kerr DA; Dong Y; Ingersoll EW; Archibald D
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):162-8. PubMed ID: 23323713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
    Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.
    Lo Coco D; Marchese S; La Bella V; Piccoli T; Lo Coco A
    Chest; 2007 Jul; 132(1):64-9. PubMed ID: 17475635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative effects of forced vital capacity and ALSFRS-R on survival in ALS.
    Daghlas SA; Govindarajan R;
    Muscle Nerve; 2021 Sep; 64(3):346-351. PubMed ID: 34076262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting functional decline and survival in amyotrophic lateral sclerosis.
    Ong ML; Tan PF; Holbrook JD
    PLoS One; 2017; 12(4):e0174925. PubMed ID: 28406915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials.
    Witzel S; Frauhammer F; Steinacker P; Devos D; Pradat PF; Meininger V; Halbgebauer S; Oeckl P; Schuster J; Anders S; Dorst J; Otto M; Ludolph AC
    Transl Neurodegener; 2021 Aug; 10(1):31. PubMed ID: 34433481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How common are ALS plateaus and reversals?
    Bedlack RS; Vaughan T; Wicks P; Heywood J; Sinani E; Selsov R; Macklin EA; Schoenfeld D; Cudkowicz M; Sherman A
    Neurology; 2016 Mar; 86(9):808-12. PubMed ID: 26658909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
    ;
    Lancet Neurol; 2017 Jul; 16(7):505-512. PubMed ID: 28522181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
    Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
    No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.